Caleres, Inc. engages in the designs, develops, sources, manufactures, and distributes footwear in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, Adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr. Martens, Reef, Asics, Bearpaw, HeyDude, and Veronica Beard brands, as well as company-owned and licensed brands, such as Sam Edelman, Vionic, Allen Edmonds, Franco Sarto, Rykä, Vince, Favorite Daughter, LifeStride, Dr. Scholl's Shoes, Blowfish Malibu, and Naturalizer. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, samedelman.co.uk, allenedmonds.com, allenedmonds.ca, shoebank.com, drschollsshoes.com, lifestride.com, francosarto.com, and ryka.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as online retailers, national chains, department stores, mass merchandisers, and independent retailers. Further, the company wholesales men's footwear, apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear collection under Veronica Beard brand. The company operates through retail shoe stores, wholesales, and e-commerce websites. The company was formerly known as Brown Shoe Company, Inc. and changed its name to Caleres, Inc. in May 2015. Caleres, Inc. was founded in 1878 and is headquartered in Saint Louis, Missouri.

Caleres, Inc.

An update from CalciMedica ( ($CALC) ) is now available. On August 31, 2026, CalciMedica reported that Nasdaq staff determined the company now sati...

CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk

Dishman Carbogen Amcis Ltd. ( ($IN:DCAL) ) just unveiled an update. Dishman Carbogen Amcis Limited has announced a change in senior management, dis...

Dishman Carbogen Amcis Announces Cessation of Vice President (Operation)

Polynovo received a Buy rating and a A$1.22 price target from Bell Potter analyst John Hester today. Hester covers the Healthcare sector, focusing ...

Bell Potter upgrades Polynovo  (CALZF) to a Buy

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Polynovo (CALZF), Clinuvel Pharmaceuticals (CLVLF)...

Analysts Offer Insights on Healthcare Companies: Polynovo (OtherCALZF), Clinuvel Pharmaceuticals (OtherCLVLF) and Impedimed Limited (OtherIPDQF)

Caledonia Investments ( ($GB:CLDN) ) has shared an announcement. Caledonia Investments has disclosed routine share transactions involving its chief...

Caledonia Executives Increase Holdings Through Share Incentive Plan

In a report released today, Scott Power from Morgans maintained a Buy rating on Polynovo , with a price target of A$1.21. According to TipRanks, Po...

Morgans Sticks to Their Buy Rating for Polynovo  (CALZF)

In a report released today, from Macquarie maintained a Buy rating on Polynovo , with a price target of A$1.30. Polynovo has an analyst consensus o...

Macquarie Keeps Their Buy Rating on Polynovo  (CALZF)

Barclays analyst Richard Hightower maintained a Hold rating on Camden Property today and set a price target of $123.00. Hightower covers the Real E...

Camden Property (CPT) Receives a Hold from Barclays

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CAL	$12.43	+2.64%	405.65K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CAL	$12.43	+2.6%	405.65K
3
4
5
6

CAL

Get Caleres, Inc. Data in Excel

Get Caleres, Inc. Data in Excel